BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 14630800)

  • 1. Heterogeneity in Fanconi anemia: evidence for 2 new genetic subtypes.
    Levitus M; Rooimans MA; Steltenpool J; Cool NF; Oostra AB; Mathew CG; Hoatlin ME; Waisfisz Q; Arwert F; de Winter JP; Joenje H
    Blood; 2004 Apr; 103(7):2498-503. PubMed ID: 14630800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complementation analysis in Fanconi anemia: assignment of the reference FA-H patient to group A.
    Joenje H; Levitus M; Waisfisz Q; D'Andrea A; Garcia-Higuera I; Pearson T; van Berkel CG; Rooimans MA; Morgan N; Mathew CG; Arwert F
    Am J Hum Genet; 2000 Sep; 67(3):759-62. PubMed ID: 10936108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway.
    Kim H; D'Andrea AD
    Genes Dev; 2012 Jul; 26(13):1393-408. PubMed ID: 22751496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair.
    Smogorzewska A; Matsuoka S; Vinciguerra P; McDonald ER; Hurov KE; Luo J; Ballif BA; Gygi SP; Hofmann K; D'Andrea AD; Elledge SJ
    Cell; 2007 Apr; 129(2):289-301. PubMed ID: 17412408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focal Point of Fanconi Anemia Signaling.
    Zhan S; Siu J; Wang Z; Yu H; Bezabeh T; Deng Y; Du W; Fei P
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicase-inactivating
    Kamal L; Pierce SB; Canavati C; Rayyan AA; Jaraysa T; Lobel O; Lolas S; Norquist BM; Rabie G; Zahdeh F; Levy-Lahad E; King MC; Kanaan MN
    Cold Spring Harb Mol Case Stud; 2020 Oct; 6(5):. PubMed ID: 33028645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fanconi Anemia Pathway: Mechanisms of Breast Cancer Predisposition Development and Potential Therapeutic Targets.
    Fang CB; Wu HT; Zhang ML; Liu J; Zhang GJ
    Front Cell Dev Biol; 2020; 8():160. PubMed ID: 32300589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotype-phenotype associations in Fanconi anemia: A literature review.
    Fiesco-Roa MO; Giri N; McReynolds LJ; Best AF; Alter BP
    Blood Rev; 2019 Sep; 37():100589. PubMed ID: 31351673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RecQ and Fe-S helicases have unique roles in DNA metabolism dictated by their unwinding directionality, substrate specificity, and protein interactions.
    Estep KN; Brosh RM
    Biochem Soc Trans; 2018 Feb; 46(1):77-95. PubMed ID: 29273621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNF-α, a good or bad factor in hematological diseases?
    Tian T; Wang M; Ma D
    Stem Cell Investig; 2014; 1():12. PubMed ID: 27358858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ataxia-Pancytopenia Syndrome Is Caused by Missense Mutations in SAMD9L.
    Chen DH; Below JE; Shimamura A; Keel SB; Matsushita M; Wolff J; Sul Y; Bonkowski E; Castella M; Taniguchi T; Nickerson D; Papayannopoulou T; Bird TD; Raskind WH
    Am J Hum Genet; 2016 Jun; 98(6):1146-1158. PubMed ID: 27259050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FANCJ suppresses microsatellite instability and lymphomagenesis independent of the Fanconi anemia pathway.
    Matsuzaki K; Borel V; Adelman CA; Schindler D; Boulton SJ
    Genes Dev; 2015 Dec; 29(24):2532-46. PubMed ID: 26637282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel FANCI mutations in Fanconi anemia with VACTERL association.
    Savage SA; Ballew BJ; Giri N; ; Chandrasekharappa SC; Ameziane N; de Winter J; Alter BP;
    Am J Med Genet A; 2016 Feb; 170A(2):386-391. PubMed ID: 26590883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Counselors' Experiences Regarding Communication of Reproductive Risks with Autosomal Recessive Conditions found on Cancer Panels.
    Mets S; Tryon R; Veach PM; Zierhut HA
    J Genet Couns; 2016 Apr; 25(2):359-72. PubMed ID: 26454646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FANCJ protein is important for the stability of FANCD2/FANCI proteins and protects them from proteasome and caspase-3 dependent degradation.
    Clark DW; Tripathi K; Dorsman JC; Palle K
    Oncotarget; 2015 Oct; 6(30):28816-32. PubMed ID: 26336824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Fanconi anemia ID2 complex: dueling saxes at the crossroads.
    Boisvert RA; Howlett NG
    Cell Cycle; 2014; 13(19):2999-3015. PubMed ID: 25486561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF-α signaling in Fanconi anemia.
    Du W; Erden O; Pang Q
    Blood Cells Mol Dis; 2014 Jan; 52(1):2-11. PubMed ID: 23890415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FAVL impairment of the Fanconi anemia pathway promotes the development of human bladder cancer.
    Panneerselvam J; Park HK; Zhang J; Dudimah FD; Zhang P; Wang H; Fei P
    Cell Cycle; 2012 Aug; 11(15):2947-55. PubMed ID: 22828653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards a molecular understanding of the fanconi anemia core complex.
    Hodson C; Walden H
    Anemia; 2012; 2012():926787. PubMed ID: 22675617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FANCJ/BRIP1 recruitment and regulation of FANCD2 in DNA damage responses.
    Zhang F; Fan Q; Ren K; Auerbach AD; Andreassen PR
    Chromosoma; 2010 Dec; 119(6):637-49. PubMed ID: 20676667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.